Mainz Biomed (MYNZ) Equity Ratio (2020 - 2024)
Historic Equity Ratio for Mainz Biomed (MYNZ) over the last 5 years, with Q4 2024 value amounting to 0.46.
- Mainz Biomed's Equity Ratio rose 11660.81% to 0.46 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.46, marking a year-over-year increase of 11660.81%. This contributed to the annual value of 0.46 for FY2024, which is 11660.81% up from last year.
- Latest data reveals that Mainz Biomed reported Equity Ratio of 0.46 as of Q4 2024, which was up 11660.81% from 0.21 recorded in Q4 2023.
- Mainz Biomed's Equity Ratio's 5-year high stood at 0.7 during Q4 2022, with a 5-year trough of 4.07 in Q4 2020.
- Its 5-year average for Equity Ratio is 0.41, with a median of 0.46 in 2024.
- Its Equity Ratio has fluctuated over the past 5 years, first crashed by 6972.12% in 2023, then surged by 11660.81% in 2024.
- Mainz Biomed's Equity Ratio (Quarter) stood at 4.07 in 2020, then surged by 115.56% to 0.63 in 2021, then increased by 9.93% to 0.7 in 2022, then tumbled by 69.72% to 0.21 in 2023, then surged by 116.61% to 0.46 in 2024.
- Its Equity Ratio stands at 0.46 for Q4 2024, versus 0.21 for Q4 2023 and 0.7 for Q4 2022.